Past Meeting Highlights
Congratulations 2022 Abstract Competition Winners!
Oral Presentations
1st Place Oral Shista Priyadarshini, MD Guthrie Robert Packer Hospital A Quality Improvement Initiative to Improve Lung Cancer Screening Rates in a Community-Based Clinic |
e-Posters
1st Place Poster Swe Swe Hlaing, MD Crozer Chester Medical Center Are the NCCN Guidelines Regarding Use of Immunotherapy for Stage III NSCLC in a Community Setting Being Followed? |
The Pennsylvania Society of Oncology and Hematology gratefully acknowledges the following organizations for supporting PSOH’s 2022 Annual Meeting
10K Corporate Members Bristol Myers Squibb Daiichi Sankyo, Inc. Gilead Janssen Pharmaceutical Companies of Johnson & Johnson Merck Regeneron Seagen |
5K Corporate Members Astellas Oncology AstraZeneca Aveo Oncology Exelixis Kyowa Kirin, Inc. MacroGenics, Inc. Pfizer Oncology Sanofi |
Exhibitors
Adaptive Biotechnologies
Alexion Alexion Pharmaceuticals Amgen Bayer BeiGene USA Blueprint Medicines BTG Specialty Pharmaceuticals Caris Life Sciences Coherus Biosciences Eisai Inc. EMD Serono Exact Sciences Foundation Medicine, Inc. |
Fox Chase Cancer Center
Genentech Guardant Health Immunocore Incyte Corp Ipsen Biopharmaceuticals Janssen Pharmaceuticals, Inc. Karius Lilly Massive Bio Pharmacosmos Therapeutics, Inc. Sanofi Sobi Stemline Therapeutics |